| Product Code: ETC6742630 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 China Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market - Industry Life Cycle |
3.4 China Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market - Porter's Five Forces |
3.5 China Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.6 China Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 China Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 China Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 China Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about exocrine pancreatic insufficiency (EPI) in China |
4.2.2 Rising prevalence of EPI cases in the Chinese population |
4.2.3 Technological advancements in EPI therapeutics and diagnostics |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of EPI therapeutics and diagnostics in China |
4.3.2 High cost associated with EPI treatments and diagnostics |
4.3.3 Limited reimbursement options for EPI patients in China |
5 China Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Trends |
6 China Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market, By Types |
6.1 China Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market, By Diagnosis |
6.1.1 Overview and Analysis |
6.1.2 China Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.1.3 China Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Imaging Tests, 2021- 2031F |
6.1.4 China Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Pancreatic Function Test, 2021- 2031F |
6.2 China Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 China Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Nutritional Management, 2021- 2031F |
6.2.3 China Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Pancreatic Enzyme Replacement Therapy, 2021- 2031F |
6.3 China Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 China Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Generic, 2021- 2031F |
6.3.3 China Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Branded, 2021- 2031F |
6.4 China Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 China Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 China Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 China Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.5 China Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
6.4.6 China Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Research and Academic Institute, 2021- 2031F |
6.4.7 China Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
7 China Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Import-Export Trade Statistics |
7.1 China Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Export to Major Countries |
7.2 China Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Imports from Major Countries |
8 China Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Key Performance Indicators |
8.1 Number of EPI cases diagnosed annually in China |
8.2 Adoption rate of advanced EPI therapeutics and diagnostics in the Chinese market |
8.3 Level of government support and initiatives for EPI awareness and treatment in China |
9 China Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market - Opportunity Assessment |
9.1 China Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.2 China Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 China Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 China Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Opportunity Assessment, By End User, 2021 & 2031F |
10 China Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market - Competitive Landscape |
10.1 China Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 China Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here